Categories: News

Novo Nordisk Gulf receives prestigious Best Places to Work Certification in Kuwait, Qatar, Bahrain, and Oman for 2024

KUWAIT CITY, KUWAIT – Media OutReach Newswire – 2 October 2024 – Novo Nordisk Gulf, a leading global healthcare company, has been recognized as one of the Best Places to Work for 2024 across Kuwait, Qatar, Bahrain, and Oman. This certification highlights the company’s dedication to fostering a supportive, innovative, and inclusive work environment for its employees while remaining committed to its mission of driving change to defeat serious chronic diseases.

During the certification process, Novo Nordisk Gulf received high ratings in key areas including employee engagement, leadership support, and workplace culture. These factors underscore the company’s success in creating a desirable workplace that aligns with its broader goal of improving health outcomes across the Gulf region.

Venkat Kalyan, Vice President & General Manager of Novo Nordisk Gulf Cluster, expressed his pride in the achievement: “We are honoured to receive the Best Place to Work recognition for Novo Nordisk Gulf Cluster. Our purpose is driving change to defeat serious chronic diseases, and this recognition serves as a testament of our commitment to this purpose, as well as our colleagues’ valuable efforts to build and sustain an innovative and inclusive workplace.”

Aydogan Cantimur, People & Organization Director at Novo Nordisk Gulf Cluster, also commented on the company’s achievement: “In Novo Nordisk Gulf Cluster, we are committed to ‘be the best workplace’ by continuously evolving our environment to the better and creating the best employee experience by implementing tangible and innovative HR practices. We are proud to be recognized as a Best Place to Work in Gulf Cluster again, which gives us the confidence that we are on the right track.”
Hashtag: #BestPlacesToWork

The issuer is solely responsible for the content of this announcement.

About Novo Nordisk

Novo Nordisk is a global healthcare company with over 95 years of innovation and leadership in diabetes care. Headquartered in Denmark, Novo Nordisk also leads in hemophilia care, growth hormone therapy, and hormone replacement therapy. The company employs approximately 70,000 people in 80 countries and markets its products in more than 170 countries.

For more information about Novo Nordisk and its commitment to the well-being of its employees and patients, visit www.novonordisk.com.

For more information, please visit www.bestplacestoworkfor.org.

LinkedIn: https://www.linkedin.com/company/best-places-to-work-program/

Twitter: http://www.twitter/bptw4

Facebook: https://www.facebook.com/bptw4all/

Miscw.com

Recent Posts

ISCA Unveils Bold Plan to Future-Proof Singapore’s Small and Medium-Sized Accounting Practices

SINGAPORE - Media OutReach Newswire - 16 December 2025 - Small and Medium-Sized Accounting Practices…

2 hours ago

Leeds Capital and MIO Trust Are Proud to Announce Their Collaboration on an AI‑Driven Multi‑Asset Trust Focused on Digital Assets and Precious Metals

SYDNEY, AUSTRALIA - Media OutReach Newswire - 16 December 2025 - Leeds Capital and MIO…

3 hours ago

Optimistic Hong Kong Ecommerce Merchants Report Growth, But Hidden Payment Friction Is Eroding Up to 10% of Revenue, Aspire Report Finds

Despite 64% reporting revenue growth, 91% of merchants face payment friction HONG KONG SAR -…

4 hours ago

Hong Kong Launches Its First Dental Innovation Incubation Programme

HONG KONG SAR - Media OutReach Newswire - 16 December 2025 - The University of…

5 hours ago

GEELY Opens Worlds Largest Vehicle Testing Centre, Meeting the New Benchmark in Global Automotive Safety

NINGBO, CHINA - Media OutReach Newswire - 16 December 2025 - Geely Auto Group today…

5 hours ago

Japan’s Hokkaido University Strengthens International Engagement Ahead of Its 150th Anniversary

“Hokkaido University 150 Initiative” Held at One&Co open space in Tanjong Pagar, SingaporeSINGAPORE - Media…

6 hours ago